Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer. (Record no. 29416890)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02219 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518024644.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202001s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1838-7640 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.7150/thno.29520 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Yu, Yong |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200114 |
245 00 - TITLE STATEMENT | |
Title | Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Theranostics |
Date of publication, distribution, etc. | 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 761-777 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibiotics, Antineoplastic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer Survivors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cellular Senescence |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Methylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA, Neoplasm |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Delivery Systems |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enhancer of Zeste Homolog 2 Protein |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epigenesis, Genetic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indazoles |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Nude |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mixed Function Oxygenases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triple Negative Breast Neoplasms |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qi, Jingjing |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xiong, Jieyi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jiang, Liping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cui, Di |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | He, Junlin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Ping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Lianjie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Chenjie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ma, Tonghui |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shao, Su |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Jianjun |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yu, Dansong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhou, Bing |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Dongsheng |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schmitt, Clemens A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tao, Ran |
773 0# - HOST ITEM ENTRY | |
Title | Theranostics |
Related parts | vol. 9 |
-- | no. 3 |
-- | p. 761-777 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.7150/thno.29520">https://doi.org/10.7150/thno.29520</a> |
Public note | Available from publisher's website |
No items available.